Editorial: Diagnosis and management of multiple sclerosis: A handful of patience

Neurology

Volumn 74, Issue 11, 2010, Pages 876-877

  Fleming, John O ^a   Carrithers, Michael D ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC ERROR; DISASTER; EDITORIAL; EXPANDED DISABILITY STATUS SCALE; FOLLOW UP; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENCE; PRIORITY JOURNAL; RELAPSE; HOSPITALIZATION; NOTE;

HUMANS; MULTIPLE SCLEROSIS; SEVERITY OF ILLNESS INDEX;

EID: 77950492275     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181d561c8     Document Type: Editorial

References (10)

1. Carmosino MJ, Brousseau KM, Arciniegas DB, Corboy JR. Initial evaluations for multiple sclerosis in a university multiple sclerosis center: outcomes and role of magnetic resonance imaging in referral. Arch Neurol 2005;62:585-590.
2. Marrie RA, Cutter G, Tyry T, Hadjimichael O, Campagnolo D, Vollmer T. Changes in the ascertainment of multiple sclerosis. Neurology 2005;65:1066-1070.
3. Whiting P, Harbord R, Main C, et al. Accuracy of magnetic resonance imaging for the diagnosis of multiple sclerosis: systematic review. BMJ 2006;332:875-884.
4. Pittock SJ, Weinshenker BG, Noseworthy JH, et al. Not every patient with multiple sclerosis should be treated at time of diagnosis. Arch Neurol 2006;63:611-614.
5. Frohman EM, Havrdova E, Lublin F, et al. Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis. Arch Neurol 2006;63:614-619.
6. Rice GP, Icorvaia B, Munari L, et al. Interferon in relapsing-remitting multiple sclerosis [updated April 2007]. Cochrane Database Syst Rev 2001;CD002002.
7. Pittock SJ. Uncertain BENEFIT of early interferon beta-1b treatment. Lancet Neurol 2009;8:970-971.
8. Bejaoui K, Rolak LA. What is the risk of permanent disability from a multiple sclerosis relapse? Neurology 2010;74:900-902.
9. Trojano M, Pellegrini F, Paolicelli D, et al. Real-life impact of early interferon-beta therapy in relapsing multiple sclerosis. Ann Neurol 2009;66:513-520.
10. National Clinical Advisory Board of the National Multiple Sclerosis Society. Expert Opinion Paper: Disease Management Consensus Statement [updated May 2008]. Available at: http://nationalmssociety.org/for-professionals/ healthcare-professionals/publications/expert-opinion-papers/index.aspx. Accessed February 4, 2010.